Antioestrogenic derivatives of nafoxidine stimulate progesterone receptor synthesis in vivo [proceedings].
D000818:Animals; D004965:Estrogen Antagonists / Q000494:pharmacology*; D005260:Female; D066298:In Vitro Techniques; D009256:Nafoxidine / Q000031:analogs & derivatives / Q000494:pharmacology*; D009281:Naphthalenes / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011980:Receptors, Progesterone / Q000096:biosynthesis* / Q000187:drug effects
D004965:Estrogen Antagonists; D009281:Naphthalenes; D011759:Pyrrolidines; D011980:Receptors, Progesterone; C023667:U-22,410A; C013372:U 10520A; D009256:Nafoxidine